Singular Selling And Marketing Expenses vs Research Development Analysis

SHG Stock

0.12 0.01 9.09%

Singular Health financial indicator trend analysis is much more than just breaking down Singular Health Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Singular Health Group is a good investment. Please check the relationship between Singular Health Selling And Marketing Expenses and its Research Development accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Singular Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling And Marketing Expenses vs Research Development

Selling And Marketing Expenses vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Singular Health Group Selling And Marketing Expenses account and Research Development. At this time, the significance of the direction appears to have strong relationship.

The correlation between Singular Health's Selling And Marketing Expenses and Research Development is 0.66. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Research Development in the same time period over historical financial statements of Singular Health Group, assuming nothing else is changed. The correlation between historical values of Singular Health's Selling And Marketing Expenses and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Singular Health Group are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Selling And Marketing Expenses i.e., Singular Health's Selling And Marketing Expenses and Research Development go up and down completely randomly.

Correlation Coefficient

0.66

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Selling And Marketing Expenses

Research Development

Most indicators from Singular Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Singular Health Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Singular Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 2.9 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 1.3 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	259.8K	389.1K	197.7K	222.1K
Interest Income	7.3K	485.8K	558.7K	586.6K

Depreciation And Amortization Interest Income

Singular Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Short Term Investments	Non Current Liabilities Total
Total Assets		-0.12	0.54	0.03	0.91	0.68	0.47	-0.79	-0.61	-0.3	0.94	0.63	-0.45	0.94	0.72	0.31	-0.05	0.57	0.1	0.94	-0.2	0.6	0.78	0.57	0.31	0.41
Short Long Term Debt Total	-0.12		-0.22	0.91	-0.46	-0.41	0.78	0.69	0.01	0.78	-0.36	0.59	-0.69	-0.36	-0.38	-0.22	-0.3	0.01	0.9	-0.39	1.0	0.62	-0.06	0.12	-0.35	0.2
Other Current Liab	0.54	-0.22		0.2	0.38	-0.12	0.15	-0.43	-0.94	-0.45	0.39	0.08	0.18	0.39	0.05	0.88	0.75	0.91	0.22	0.53	-0.25	0.01	0.85	0.94	0.92	0.87
Total Current Liabilities	0.03	0.91	0.2		-0.38	-0.53	0.81	0.57	-0.37	0.6	-0.27	0.56	-0.56	-0.27	-0.42	0.13	0.05	0.38	1.0	-0.24	0.9	0.56	0.24	0.5	0.04	0.57
Total Stockholder Equity	0.91	-0.46	0.38	-0.38		0.87	0.13	-0.95	-0.39	-0.49	0.99	0.38	-0.22	0.99	0.84	0.22	-0.11	0.35	-0.31	0.97	-0.53	0.36	0.62	0.29	0.24	0.11
Net Tangible Assets	0.68	-0.41	-0.12	-0.53	0.87		0.03	-0.8	0.07	-0.29	0.84	0.35	-0.32	0.84	0.9	-0.24	-0.52	-0.1	-0.48	0.75	-0.46	0.36	0.21	-0.2	-0.23	-0.36
Property Plant And Equipment Net	0.47	0.78	0.15	0.81	0.13	0.03		0.16	-0.43	0.62	0.21	0.94	-0.91	0.21	0.17	0.01	-0.35	0.45	0.84	0.17	0.73	0.94	0.48	0.45	-0.12	0.37
Net Debt	-0.79	0.69	-0.43	0.57	-0.95	-0.8	0.16		0.35	0.71	-0.92	-0.09	-0.08	-0.92	-0.75	-0.3	-0.08	-0.3	0.52	-0.93	0.75	-0.06	-0.53	-0.25	-0.36	-0.1
Retained Earnings	-0.61	0.01	-0.94	-0.37	-0.39	0.07	-0.43	0.35		0.17	-0.41	-0.37	0.11	-0.41	-0.17	-0.8	-0.52	-0.99	-0.39	-0.52	0.06	-0.3	-0.94	-0.96	-0.79	-0.83
Accounts Payable	-0.3	0.78	-0.45	0.6	-0.49	-0.29	0.62	0.71	0.17		-0.48	0.54	-0.67	-0.48	-0.1	-0.48	-0.6	-0.09	0.59	-0.56	0.78	0.56	-0.2	-0.21	-0.6	-0.26
Cash	0.94	-0.36	0.39	-0.27	0.99	0.84	0.21	-0.92	-0.41	-0.48		0.44	-0.28	1.0	0.78	0.25	-0.1	0.36	-0.21	0.99	-0.43	0.42	0.64	0.34	0.26	0.19
Non Current Assets Total	0.63	0.59	0.08	0.56	0.38	0.35	0.94	-0.09	-0.37	0.54	0.44		-0.96	0.44	0.48	-0.1	-0.53	0.39	0.61	0.37	0.53	1.0	0.5	0.33	-0.22	0.17
Non Currrent Assets Other	-0.45	-0.69	0.18	-0.56	-0.22	-0.32	-0.91	-0.08	0.11	-0.67	-0.28	-0.96		-0.28	-0.4	0.32	0.7	-0.14	-0.6	-0.19	-0.64	-0.98	-0.26	-0.09	0.45	0.03
Cash And Short Term Investments	0.94	-0.36	0.39	-0.27	0.99	0.84	0.21	-0.92	-0.41	-0.48	1.0	0.44	-0.28		0.78	0.25	-0.1	0.36	-0.21	0.99	-0.43	0.42	0.64	0.34	0.26	0.19
Net Receivables	0.72	-0.38	0.05	-0.42	0.84	0.9	0.17	-0.75	-0.17	-0.1	0.78	0.48	-0.4	0.78		-0.18	-0.5	0.19	-0.36	0.71	-0.44	0.47	0.39	-0.03	-0.17	-0.28
Common Stock Shares Outstanding	0.31	-0.22	0.88	0.13	0.22	-0.24	0.01	-0.3	-0.8	-0.48	0.25	-0.1	0.32	0.25	-0.18		0.79	0.74	0.13	0.39	-0.24	-0.16	0.75	0.81	0.97	0.8
Other Current Assets	-0.05	-0.3	0.75	0.05	-0.11	-0.52	-0.35	-0.08	-0.52	-0.6	-0.1	-0.53	0.7	-0.1	-0.5	0.79		0.48	0.03	0.06	-0.28	-0.58	0.32	0.62	0.88	0.73
Other Stockholder Equity	0.57	0.01	0.91	0.38	0.35	-0.1	0.45	-0.3	-0.99	-0.09	0.36	0.39	-0.14	0.36	0.19	0.74	0.48		0.41	0.46	-0.04	0.31	0.92	0.93	0.74	0.79
Total Liab	0.1	0.9	0.22	1.0	-0.31	-0.48	0.84	0.52	-0.39	0.59	-0.21	0.61	-0.6	-0.21	-0.36	0.13	0.03	0.41		-0.18	0.88	0.6	0.28	0.53	0.04	0.57
Total Current Assets	0.94	-0.39	0.53	-0.24	0.97	0.75	0.17	-0.93	-0.52	-0.56	0.99	0.37	-0.19	0.99	0.71	0.39	0.06	0.46	-0.18		-0.46	0.34	0.71	0.47	0.41	0.33
Short Term Debt	-0.2	1.0	-0.25	0.9	-0.53	-0.46	0.73	0.75	0.06	0.78	-0.43	0.53	-0.64	-0.43	-0.44	-0.24	-0.28	-0.04	0.88	-0.46		0.55	-0.13	0.08	-0.36	0.17
Intangible Assets	0.6	0.62	0.01	0.56	0.36	0.36	0.94	-0.06	-0.3	0.56	0.42	1.0	-0.98	0.42	0.47	-0.16	-0.58	0.31	0.6	0.34	0.55		0.44	0.26	-0.28	0.12
Common Stock	0.78	-0.06	0.85	0.24	0.62	0.21	0.48	-0.53	-0.94	-0.2	0.64	0.5	-0.26	0.64	0.39	0.75	0.32	0.92	0.28	0.71	-0.13	0.44		0.87	0.7	0.7
Property Plant Equipment	0.57	0.12	0.94	0.5	0.29	-0.2	0.45	-0.25	-0.96	-0.21	0.34	0.33	-0.09	0.34	-0.03	0.81	0.62	0.93	0.53	0.47	0.08	0.26	0.87		0.81	0.95
Short Term Investments	0.31	-0.35	0.92	0.04	0.24	-0.23	-0.12	-0.36	-0.79	-0.6	0.26	-0.22	0.45	0.26	-0.17	0.97	0.88	0.74	0.04	0.41	-0.36	-0.28	0.7	0.81		0.81
Non Current Liabilities Total	0.41	0.2	0.87	0.57	0.11	-0.36	0.37	-0.1	-0.83	-0.26	0.19	0.17	0.03	0.19	-0.28	0.8	0.73	0.79	0.57	0.33	0.17	0.12	0.7	0.95	0.81

Click cells to compare fundamentals

Singular Health Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Singular Stock Analysis

When running Singular Health's price analysis, check to measure Singular Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Health is operating at the current time. Most of Singular Health's value examination focuses on studying past and present price action to predict the probability of Singular Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Health's price. Additionally, you may evaluate how the addition of Singular Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Singular Selling And Marketing Expenses vs Research Development Analysis

Selling And Marketing Expenses vs Research Development

Selling And Marketing Expenses vs Research Development Correlation Analysis

Correlation Coefficient

Selling And Marketing Expenses

Research Development

Singular Health fundamental ratios Correlations

Singular Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Singular Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Term Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Intangible Assets	+ 1.0	Non Current Assets Total
Cash	+ 0.99	Total Stockholder Equity
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity

Other Stockholder Equity	- 0.99	Retained Earnings
Intangible Assets	- 0.98	Non Currrent Assets Other
Non Currrent Assets Other	- 0.96	Non Current Assets Total
Property Plant Equipment	- 0.96	Retained Earnings
Net Debt	- 0.95	Total Stockholder Equity
Common Stock	- 0.94	Retained Earnings